Clinical Trials Logo

Respiratory Failure clinical trials

View clinical trials related to Respiratory Failure.

Filter by:

NCT ID: NCT01370278 Completed - Clinical trials for Myocardial Infarction

Clearance Of Mucus In Stents (COMIS)

Start date: June 16, 2011
Phase: N/A
Study type: Interventional

The goal of this clinical research study is to compare the effects of sodium bicarbonate to normal saline when used for clearing mucus blockage in patients with airway stents.

NCT ID: NCT01339533 Recruiting - Respiratory Failure Clinical Trials

Airway Pressure Release Ventilation (APRV) Versus AC/VC Conventional Ventilation

Start date: October 2011
Phase: Phase 2
Study type: Interventional

APRV mode of ventilation will result in an improved partial pressure of arterial oxygenation/ fraction of inspired oxygen (P/F ratio) on day 3 of mechanical ventilation. Sub hypotheses: APRV will be associated with a reduced amount of sedation used during the ICU stay in patients with respiratory failure. APRV will be associated with a reduction in the amount of vasoactive medication used for blood pressure support in patients with respiratory failure.

NCT ID: NCT01337271 Completed - Respiratory Failure Clinical Trials

Performance of Neurally Adjusted Ventilatory Assist (NAVA) During Spontaneous Breathing Trial

Start date: May 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to compare a new mode of mechanical ventilation (NAVA, or Neurally adjusted Ventilatory assist) with a traditional mode (Pressure Support ventilation) on its the ability to detect patients ready for extubation (liberation from mechanical ventilation).

NCT ID: NCT01335932 Completed - Clinical trials for Acute Respiratory Distress Syndrome

Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure

GRAIL
Start date: March 10, 2011
Phase: Phase 2
Study type: Interventional

To evaluate whether administration of ganciclovir reduces serum IL-6 levels (i.e. reduction between baseline and 14 days post-randomization) in immunocompetent adults with severe sepsis or trauma associated respiratory failure. Primary Hypotheses: - In CMV seropositive adults with severe sepsis or trauma , pulmonary and systemic CMV reactivation amplifies and perpetuates both lung and systemic inflammation mediated through specific cytokines, and contributes to pulmonary injury and multiorgan system failure, AND - Prevention of CMV reactivation with ganciclovir decreases pulmonary and systemic inflammatory cytokines that are important in the pathogenesis of sepsis and trauma related complications.

NCT ID: NCT01333059 Terminated - Respiratory Failure Clinical Trials

Cycling of Sedative Infusions in Critically Ill Pediatric Patients

Start date: September 2010
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if the reduction of the total amount of sedative critically pediatric ill patients receive in the PICU will achieve a significant decrease in mechanical ventilation days and a decrease in the overall length of stay in the PICU and hospital.

NCT ID: NCT01326208 Recruiting - Clinical trials for Acute Respiratory Distress Syndrome

Strategies to Optimize Positive End-expiratory Pressure (PEEP) in Patients With Acute Lung Injury

EIT-PEEP
Start date: March 2011
Phase: Phase 2
Study type: Interventional

The purpose of this study in patients suffering from acute lung injury is to determine whether positive end-expiratory pressure (PEEP) setting guided by electrical impedance tomography (EIT) influences pulmonary gas exchange, lung mechanics, ventilation/perfusion matching and homogeneity of regional ventilation when compared to other PEEP setting strategies such as the open lung concept or the ARDSnet protocol.

NCT ID: NCT01306201 Completed - Respiratory Failure Clinical Trials

Novel Non-Invasive Monitoring Parameter in a Hospital Setting

Start date: February 2011
Phase: N/A
Study type: Observational

Data collected from this study will be used to evaluate the performance of a monitoring algorithm.

NCT ID: NCT01286610 Completed - Sepsis Clinical Trials

Applicability and Safety of Vibration Therapy in Intensive Care Unit (ICU) Patients

VTICU
Start date: February 2011
Phase: N/A
Study type: Interventional

Vibration therapy is used for different indications in rehabilitation and sports medicine. So far, vibration therapy has not been investigated within the ICU setting. The investigators created this setting to show safety and applicability of vibration therapy in ICU patients. 30 patients will be stimulated by vibration therapy on two separate days during their ICU stay. Three collectives of equal size will be observed: One with patients on mechanical ventilation without signs of infection or suspected intracranial pressure problems, a second one with patients on mechanical ventilation in addition to signs of systemic inflammation but absence of suspected intracranial pressure problems, and a third one with patients on mechanical ventilation, signs of systemic inflammation in addition to presence of controlled intracranial pressure problems. Typical parameters of hemodynamic status, intracranial pressure and energy metabolism will be recorded for a defined period of time before, during and after vibration therapy itself. Vibration therapy will be combined with protocol based physiotherapy. Our aim is to show the effects of vibration therapy in ICU patients and its safe applicability. ADDITION 06th of May 2011: Additionally we will perform euglycaemic hyperinsulinemic clamp and intervention on one day of ICU stay in 20 patients. Under clamp conditions we will perform a vibration therapy (ProMedVi Vibrosphere™) on patients' legs. On top we will perform electrical muscle stimulation (schwa-medico, MUSKELaktiv™) on one ventral upper leg, randomized chosen. Measuring the local skeletal muscle metabolism will be done by microdialysis in Vastus lateralis on both sides - comparing vibration therapy and vibration therapy combined with electrical muscle stimulation.

NCT ID: NCT01286506 Terminated - Critical Illness Clinical Trials

Observational Study of Blood Pressure Measurements and Continuous Dialysis

Start date: February 2011
Phase: N/A
Study type: Observational

Dialysis is used to control the fluid balance and metabolic state of patients with kidney disease. Control of the metabolic state, via electrolytes, can be monitored using labs that are routinely drawn from patients undergoing continuous hemodialysis. Control of fluid removal is much more difficult. This study aims to determine whether changes in the blood pressure associated with breathing correlate with or predict intolerance to fluid responsiveness with continuous dialysis. We hypothesize that a measurement of changes in blood pressure with breathing called arterial pulse pressure variation may be able to predict the ability to remove fluid during continuous renal replacement therapy.

NCT ID: NCT01284140 Completed - Critical Illness Clinical Trials

Improving the Sleep and Circadian Rhythms of Mechanically Ventilated Patients

Start date: January 2011
Phase: N/A
Study type: Interventional

The goal of this project is to determine whether the sleep and circadian rhythms of critically ill patients undergoing mechanical ventilation can be improved through practical strategies that can be employed at the bedside.